Ira Kurtz, MD, FRCP, FASN, is Distinguished Professor of Medicine, Chief of the Division of Nephrology, Factor Chair in Molecular Nephrology, and a member of the UCLA Brain Research Institute.
Dr. Kurtz is a graduate of the University of Toronto, and completed his postgraduate training at both the University of California, San Francisco, and the National Institutes of Health. Dr. Kurtz has been a faculty member at UCLA since 1985 and is board-certified in Internal Medicine by the American Board of Internal Medicine and in Nephrology by the American Board of Nephrology. Dr. Kurtz is a Fellow of the Royal College of Physicians and Surgeons of Canada, and the American Society of Nephrology, and has been listed in Southern California Super Doctors. He is a member of the American Society of Clinical Investigation, the American Physiological Society, the Biophysical Society, and the American Society of Nephrology. Dr. Kurtz has authored over 300 scientific publications, book chapters, and abstracts. He is on the editorial board of several scientific journals and is an external reviewer of major scientific publications and grants.
Dr. Kurtz’s primary areas of research are ion transport-related diseases, the structural biology of membrane transport proteins, the physiology and biophysics of transport processes in the kidney and extrarenal organs, the development of an artificial kidney and artificial intelligence in the training and practice of Nephrology.
- Molecular Pathogenesis of Renal Tubular Acidosis: A Tale of Water and Baking Soda
- Complex Acid Base Disorders Diagnosis and Approach - 2019 (VuMedi login required)
- Mixed Acid Base Disorders - July 2019 (VuMedi login required)
- Introduction to Acid Base Diagnosis - July 2018 (VuMedi login required)
Medical Board Certifications
- Southern California Super Doctors® 2012
- Angion Biomedica Corporation (01/13/17- 02/21/21)
- Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function
- Fuzionaire, Inc. (04/01/18 - 03/31/21)
- Aminoacylase 3 (AA3) Inhibition: A Novel Cancer Therapy
- NIH/NIDDK (03/19/19 - 03/31/24)
- The Biology of NBCe1 in Health and Disease
- Kidney X Prize (2019)